Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.

Even the company behind ‘Wegovy’ couldn’t avoid restructuring. U.S. pharmaceutical giant MSD, which holds the highest-selling ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 12, 2025 /EINPresswire.com/ -- Genetic Analysis Market Growth Forecast: What To Expect By 2025? The market size for genetic analysis has seen a swift ...

The global single cell multiomics market size was worth around USD 3.2 billion in 2024 and is predicted to grow to around USD 22.4 billion by 2034 ...

Artificial intelligence is now better than humans at identifying many patterns, but evolutionary relationships have always ...

Asthma is a chronic respiratory condition marked by airway inflammation, narrowing, and episodes of wheezing, coughing, and ...

Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein ...

The company is a biotechnology firm engaged in the research and development, production, and sales of protein testing ...

Proteomics has emerged as a critical discipline for elucidating biological mechanisms, exploring disease pathogenesis, and ...

The key market opportunities in next-generation oncology devices include enhancing precision diagnostics and targeted ...

Researchers have discovered the first genetic mutation associated with hypertrophic cardiomyopathy (HCM) and sudden death in ...

The acquisition joins SeqOne's platform for sequencing analysis with Congenica's clinical decision support technology.